Damele, L., Amaro, A., Serio, A., Luchetti, S., Pfeffer, U., Mingari, M. C., & Vitale, C. (2021). EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34(+) Cells. Cancers (Basel).

Damele, Laura, Adriana Amaro, Alberto Serio, Silvia Luchetti, Ulrich Pfeffer, Maria Cristina Mingari, und Chiara Vitale. "EZH1/2 Inhibitors Favor ILC3 Development From Human HSPC-CD34(+) Cells." Cancers (Basel) 2021.

Damele, Laura, et al. "EZH1/2 Inhibitors Favor ILC3 Development From Human HSPC-CD34(+) Cells." Cancers (Basel) 2021.